http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-8005061-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24ee24573c48d111446592143ef1abe8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-14
filingDate 1980-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f6899776f79dc67d708e94a2b127ee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf612b3e9a8ca128879217774df62007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd695b4f82bef694dc0f4eb12eed4795
publicationDate 1981-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-8005061-L
titleOfInvention MANUFACTURED TO MAKE BIO-COMPATIBLE MATERIALS BY IMMOBILIZATION OF APYRAS ON THE SURFACE
abstract A prosthetic polymer material is made non-thrombogenic by immobilizing apyrase on its surface. Immobilization is preferably carried out by hydrolytically activating the surface of a polyamide polymer or a polyethylene terphthalate polymer, and treating the hydrolyzed polymer with a solution of cross-linking agent and a solution of apyrase. The apyrase converts adenosine diphosphate to adenosine monophosphate and adenosine whereby the formation of thrombi is inhibited.
priorityDate 1979-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5MY95
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO75355
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6NQA8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO96559
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5DRK1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF4JSH1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9SPM5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2QYE1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8H1D8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432787922
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP55772
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO18956
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO80612
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB3A0N5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6Z4P2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448378
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8K0L2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE0D877
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9USP2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9SQG2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8H7L6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP80595
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP40009
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9XI62
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP97687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554679
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO93295
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0JND9

Total number of triples: 52.